Systematic Reviews
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Jun 27, 2023; 15(6): 850-866
Published online Jun 27, 2023. doi: 10.4254/wjh.v15.i6.850
Management of sepsis in a cirrhotic patient admitted to the intensive care unit: A systematic literature review
Nkola Ndomba, Jonathan Soldera
Nkola Ndomba, Jonathan Soldera, Acute Medicine, University of South Wales, Cardiff CF37 1DL, United Kingdom
Author contributions: Both authors contributed to writing and reviewing the final draft of the manuscript.
Conflict-of-interest statement: All the authors declare no conflict of interest.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Jonathan Soldera, MD, MSc, Associate Professor, Staff Physician, Acute Medicine, University of South Wales, University of South Wales, Cardiff CF37 1DL, United Kingdom, Cardiff CF37 1DL, United Kingdom. jonathansoldera@gmail.com
Received: April 8, 2023
Peer-review started: April 8, 2023
First decision: May 4, 2023
Revised: May 22, 2023
Accepted: May 31, 2023
Article in press: May 31, 2023
Published online: June 27, 2023
Processing time: 77 Days and 17.4 Hours
Core Tip

Core Tip: Sepsis is a severe condition encountered in the intensive care unit (ICU), and when it occurs in cirrhotic patients, it often leads to high mortality due to impaired immunity and multiorgan failure. To diagnose and monitor sepsis in cirrhotic patients, various scoring systems have been developed, including the Sequential Organ Failure Assessment (SOFA) score, the Chronic Liver Failure-Sequential Organ Failure Assessment (CLIF-SOFA) score, quick SOFA (qSOFA), Model for End-Stage Liver Disease (MELD), and MELD-Na score. Although the proposed current management of sepsis in cirrhotic patients might follow the guidelines proposed by the Surviving Sepsis Campaign, this approach has might not cause significant improvement in patient outcomes. Therefore, early recognition of infection and its source is critical, followed by timely initiation of antibiotic therapy, fluid resuscitation with albumin (5% or 20%), vasopressors, and low-dose corticosteroids such as hydrocortisone. Studies have shown that this approach reduces mortality in the ICU. In addition to pharmacological interventions, interventions to control the source of infection, such as surgical drainage, may also be necessary. Finally, procalcitonin levels can be used as a diagnostic biomarker in cirrhotic patients with sepsis, helping to guide antibiotic therapy and improve patient outcomes. In conclusion, timely recognition and management of sepsis in cirrhotic patients in the ICU is crucial, and early initiation of appropriate interventions, including antibiotics, fluids, and corticosteroids, may improve patient outcomes.